2-hydroxy-N-[1-(2-methylpropyl)piperidin-4-yl]acetamide;2-hydroxy-N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]acetamide;4-methoxy-1-(2-methylpropyl)piperidine;[4-(2-methylpropyl)morpholin-2-yl]methanamine;[(2R)-1-(2-methylpropyl)piperazin-2-yl]methanol;[(2S)-1-(2-methylpropyl)piperazin-2-yl]methanol;(2S)-1-(2-methylpropyl)pyrrolidin-2-amine;(2R)-1-(2-methylpropyl)pyrrolidin-2-amine;N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]cyclopropanecarboxamide

C86H181N17O9 — CID 167595298

IUPAC2-hydroxy-N-[1-(2-methylpropyl)piperidin-4-yl]acetamide;2-hydroxy-N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]acetamide;4-methoxy-1-(2-methylpropyl)piperidine;[4-(2-methylpropyl)morpholin-2-yl]methanamine;[(2R)-1-(2-methylpropyl)piperazin-2-yl]methanol;[(2S)-1-(2-methylpropyl)piperazin-2-yl]methanol;(2S)-1-(2-methylpropyl)pyrrolidin-2-amine;(2R)-1-(2-methylpropyl)pyrrolidin-2-amine;N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]cyclopropanecarboxamide
SMILESCC(C)CN1CCC(NC(=O)CO)CC1.CC(C)CN1CCC[C@@H]1N.CC(C)CN1CCC[C@H]1N.CC(C)CN1CCNC[C@@H]1CO.CC(C)CN1CCNC[C@H]1CO.CC(C)CN1CCOC(CN)C1.CC(C)CN1CC[C@@H](NC(=O)C2CC2)C1.CC(C)CN1CC[C@@H](NC(=O)CO)C1.COC1CCN(CC(C)C)CC1
InChIInChI=1S/C12H22N2O.C11H22N2O2.C10H20N2O2.C10H21NO.3C9H20N2O.2C8H18N2/c1-9(2)7-14-6-5-11(8-14)13-12(15)10-3-4-10;1-9(2)7-13-5-3-10(4-6-13)12-11(15)8-14;1-8(2)5-12-4-3-9(6-12)11-10(14)7-13;1-9(2)8-11-6-4-10(12-3)5-7-11;1-8(2)6-11-3-4-12-9(5-10)7-11;2*1-8(2)6-11-4-3-10-5-9(11)7-12;2*1-7(2)6-10-5-3-4-8(10)9/h9-11H,3-8H2,1-2H3,(H,13,15);9-10,14H,3-8H2,1-2H3,(H,12,15);8-9,13H,3-7H2,1-2H3,(H,11,14);9-10H,4-8H2,1-3H3;8-9H,3-7,10H2,1-2H3;2*8-10,12H,3-7H2,1-2H3;2*7-8H,3-6,9H2,1-2H3/t11-;;9-;;;2*9-;2*8-/m1.1..1010/s1
InChIKeyIZEFIJLRWDEWSV-MBJBEPOESA-N
MW1597.50 g/mol
LogP5.20
Rot. Bonds28

About 2-hydroxy-N-[1-(2-methylpropyl)piperidin-4-yl]acetamide;2-hydroxy-N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]acetamide;4-methoxy-1-(2-methylpropyl)piperidine;[4-(2-methylpropyl)morpholin-2-yl]methanamine;[(2R)-1-(2-methylpropyl)piperazin-2-yl]methanol;[(2S)-1-(2-methylpropyl)piperazin-2-yl]methanol;(2S)-1-(2-methylpropyl)pyrrolidin-2-amine;(2R)-1-(2-methylpropyl)pyrrolidin-2-amine;N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]cyclopropanecarboxamide

2-hydroxy-N-[1-(2-methylpropyl)piperidin-4-yl]acetamide;2-hydroxy-N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]acetamide;4-methoxy-1-(2-methylpropyl)piperidine;[4-(2-methylpropyl)morpholin-2-yl]methanamine;[(2R)-1-(2-methylpropyl)piperazin-2-yl]methanol;[(2S)-1-(2-methylpropyl)piperazin-2-yl]methanol;(2S)-1-(2-methylpropyl)pyrrolidin-2-amine;(2R)-1-(2-methylpropyl)pyrrolidin-2-amine;N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]cyclopropanecarboxamide (PubChem CID 167595298) has the molecular formula C86H181N17O9 and a molecular weight of 1597.50 g/mol. Its IUPAC name is 2-hydroxy-N-[1-(2-methylpropyl)piperidin-4-yl]acetamide;2-hydroxy-N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]acetamide;4-methoxy-1-(2-methylpropyl)piperidine;[4-(2-methylpropyl)morpholin-2-yl]methanamine;[(2R)-1-(2-methylpropyl)piperazin-2-yl]methanol;[(2S)-1-(2-methylpropyl)piperazin-2-yl]methanol;(2S)-1-(2-methylpropyl)pyrrolidin-2-amine;(2R)-1-(2-methylpropyl)pyrrolidin-2-amine;N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]cyclopropanecarboxamide.

Molecular Properties

Compound Name2-hydroxy-N-[1-(2-methylpropyl)piperidin-4-yl]acetamide;2-hydroxy-N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]acetamide;4-methoxy-1-(2-methylpropyl)piperidine;[4-(2-methylpropyl)morpholin-2-yl]methanamine;[(2R)-1-(2-methylpropyl)piperazin-2-yl]methanol;[(2S)-1-(2-methylpropyl)piperazin-2-yl]methanol;(2S)-1-(2-methylpropyl)pyrrolidin-2-amine;(2R)-1-(2-methylpropyl)pyrrolidin-2-amine;N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]cyclopropanecarboxamide
PubChem CID167595298
Molecular FormulaC86H181N17O9
Molecular Weight1597.50 g/mol
Exact Mass1596.42
IUPAC Name2-hydroxy-N-[1-(2-methylpropyl)piperidin-4-yl]acetamide;2-hydroxy-N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]acetamide;4-methoxy-1-(2-methylpropyl)piperidine;[4-(2-methylpropyl)morpholin-2-yl]methanamine;[(2R)-1-(2-methylpropyl)piperazin-2-yl]methanol;[(2S)-1-(2-methylpropyl)piperazin-2-yl]methanol;(2S)-1-(2-methylpropyl)pyrrolidin-2-amine;(2R)-1-(2-methylpropyl)pyrrolidin-2-amine;N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]cyclopropanecarboxamide
SMILESCC(C)CN1CCC(NC(=O)CO)CC1.CC(C)CN1CCC[C@@H]1N.CC(C)CN1CCC[C@H]1N.CC(C)CN1CCNC[C@@H]1CO.CC(C)CN1CCNC[C@H]1CO.CC(C)CN1CCOC(CN)C1.CC(C)CN1CC[C@@H](NC(=O)C2CC2)C1.CC(C)CN1CC[C@@H](NC(=O)CO)C1.COC1CCN(CC(C)C)CC1
InChIInChI=1S/C12H22N2O.C11H22N2O2.C10H20N2O2.C10H21NO.3C9H20N2O.2C8H18N2/c1-9(2)7-14-6-5-11(8-14)13-12(15)10-3-4-10;1-9(2)7-13-5-3-10(4-6-13)12-11(15)8-14;1-8(2)5-12-4-3-9(6-12)11-10(14)7-13;1-9(2)8-11-6-4-10(12-3)5-7-11;1-8(2)6-11-3-4-12-9(5-10)7-11;2*1-8(2)6-11-4-3-10-5-9(11)7-12;2*1-7(2)6-10-5-3-4-8(10)9/h9-11H,3-8H2,1-2H3,(H,13,15);9-10,14H,3-8H2,1-2H3,(H,12,15);8-9,13H,3-7H2,1-2H3,(H,11,14);9-10H,4-8H2,1-3H3;8-9H,3-7,10H2,1-2H3;2*8-10,12H,3-7H2,1-2H3;2*7-8H,3-6,9H2,1-2H3/t11-;;9-;;;2*9-;2*8-/m1.1..1010/s1
InChIKeyIZEFIJLRWDEWSV-MBJBEPOESA-N
XLogP5.20
TPSA317.96 Ų
H-Bond Donors12
H-Bond Acceptors23
Rotatable Bonds28
Heavy Atoms112
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001597.50
LogP ≤ 55.20
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1023

Analyze 2-hydroxy-N-[1-(2-methylpropyl)piperidin-4-yl]acetamide;2-hydroxy-N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]acetamide;4-methoxy-1-(2-methylpropyl)piperidine;[4-(2-methylpropyl)morpholin-2-yl]methanamine;[(2R)-1-(2-methylpropyl)piperazin-2-yl]methanol;[(2S)-1-(2-methylpropyl)piperazin-2-yl]methanol;(2S)-1-(2-methylpropyl)pyrrolidin-2-amine;(2R)-1-(2-methylpropyl)pyrrolidin-2-amine;N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]cyclopropanecarboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-hydroxy-N-[1-(2-methylpropyl)piperidin-4-yl]acetamide;2-hydroxy-N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]acetamide;4-methoxy-1-(2-methylpropyl)piperidine;[4-(2-methylpropyl)morpholin-2-yl]methanamine;[(2R)-1-(2-methylpropyl)piperazin-2-yl]methanol;[(2S)-1-(2-methylpropyl)piperazin-2-yl]methanol;(2S)-1-(2-methylpropyl)pyrrolidin-2-amine;(2R)-1-(2-methylpropyl)pyrrolidin-2-amine;N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]cyclopropanecarboxamide?
The IUPAC name of 2-hydroxy-N-[1-(2-methylpropyl)piperidin-4-yl]acetamide;2-hydroxy-N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]acetamide;4-methoxy-1-(2-methylpropyl)piperidine;[4-(2-methylpropyl)morpholin-2-yl]methanamine;[(2R)-1-(2-methylpropyl)piperazin-2-yl]methanol;[(2S)-1-(2-methylpropyl)piperazin-2-yl]methanol;(2S)-1-(2-methylpropyl)pyrrolidin-2-amine;(2R)-1-(2-methylpropyl)pyrrolidin-2-amine;N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]cyclopropanecarboxamide (CID 167595298) is 2-hydroxy-N-[1-(2-methylpropyl)piperidin-4-yl]acetamide;2-hydroxy-N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]acetamide;4-methoxy-1-(2-methylpropyl)piperidine;[4-(2-methylpropyl)morpholin-2-yl]methanamine;[(2R)-1-(2-methylpropyl)piperazin-2-yl]methanol;[(2S)-1-(2-methylpropyl)piperazin-2-yl]methanol;(2S)-1-(2-methylpropyl)pyrrolidin-2-amine;(2R)-1-(2-methylpropyl)pyrrolidin-2-amine;N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]cyclopropanecarboxamide.
What is the SMILES notation for 2-hydroxy-N-[1-(2-methylpropyl)piperidin-4-yl]acetamide;2-hydroxy-N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]acetamide;4-methoxy-1-(2-methylpropyl)piperidine;[4-(2-methylpropyl)morpholin-2-yl]methanamine;[(2R)-1-(2-methylpropyl)piperazin-2-yl]methanol;[(2S)-1-(2-methylpropyl)piperazin-2-yl]methanol;(2S)-1-(2-methylpropyl)pyrrolidin-2-amine;(2R)-1-(2-methylpropyl)pyrrolidin-2-amine;N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]cyclopropanecarboxamide?
The canonical SMILES for 2-hydroxy-N-[1-(2-methylpropyl)piperidin-4-yl]acetamide;2-hydroxy-N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]acetamide;4-methoxy-1-(2-methylpropyl)piperidine;[4-(2-methylpropyl)morpholin-2-yl]methanamine;[(2R)-1-(2-methylpropyl)piperazin-2-yl]methanol;[(2S)-1-(2-methylpropyl)piperazin-2-yl]methanol;(2S)-1-(2-methylpropyl)pyrrolidin-2-amine;(2R)-1-(2-methylpropyl)pyrrolidin-2-amine;N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]cyclopropanecarboxamide is CC(C)CN1CCC(NC(=O)CO)CC1.CC(C)CN1CCC[C@@H]1N.CC(C)CN1CCC[C@H]1N.CC(C)CN1CCNC[C@@H]1CO.CC(C)CN1CCNC[C@H]1CO.CC(C)CN1CCOC(CN)C1.CC(C)CN1CC[C@@H](NC(=O)C2CC2)C1.CC(C)CN1CC[C@@H](NC(=O)CO)C1.COC1CCN(CC(C)C)CC1.
What is the InChIKey of 2-hydroxy-N-[1-(2-methylpropyl)piperidin-4-yl]acetamide;2-hydroxy-N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]acetamide;4-methoxy-1-(2-methylpropyl)piperidine;[4-(2-methylpropyl)morpholin-2-yl]methanamine;[(2R)-1-(2-methylpropyl)piperazin-2-yl]methanol;[(2S)-1-(2-methylpropyl)piperazin-2-yl]methanol;(2S)-1-(2-methylpropyl)pyrrolidin-2-amine;(2R)-1-(2-methylpropyl)pyrrolidin-2-amine;N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]cyclopropanecarboxamide?
The InChIKey is IZEFIJLRWDEWSV-MBJBEPOESA-N. The full InChI is InChI=1S/C12H22N2O.C11H22N2O2.C10H20N2O2.C10H21NO.3C9H20N2O.2C8H18N2/c1-9(2)7-14-6-5-11(8-14)13-12(15)10-3-4-10;1-9(2)7-13-5-3-10(4-6-13)12-11(15)8-14;1-8(2)5-12-4-3-9(6-12)11-10(14)7-13;1-9(2)8-11-6-4-10(12-3)5-7-11;1-8(2)6-11-3-4-12-9(5-10)7-11;2*1-8(2)6-11-4-3-10-5-9(11)7-12;2*1-7(2)6-10-5-3-4-8(10)9/h9-11H,3-8H2,1-2H3,(H,13,15);9-10,14H,3-8H2,1-2H3,(H,12,15);8-9,13H,3-7H2,1-2H3,(H,11,14);9-10H,4-8H2,1-3H3;8-9H,3-7,10H2,1-2H3;2*8-10,12H,3-7H2,1-2H3;2*7-8H,3-6,9H2,1-2H3/t11-;;9-;;;2*9-;2*8-/m1.1..1010/s1.
What are the key properties of 2-hydroxy-N-[1-(2-methylpropyl)piperidin-4-yl]acetamide;2-hydroxy-N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]acetamide;4-methoxy-1-(2-methylpropyl)piperidine;[4-(2-methylpropyl)morpholin-2-yl]methanamine;[(2R)-1-(2-methylpropyl)piperazin-2-yl]methanol;[(2S)-1-(2-methylpropyl)piperazin-2-yl]methanol;(2S)-1-(2-methylpropyl)pyrrolidin-2-amine;(2R)-1-(2-methylpropyl)pyrrolidin-2-amine;N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]cyclopropanecarboxamide?
2-hydroxy-N-[1-(2-methylpropyl)piperidin-4-yl]acetamide;2-hydroxy-N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]acetamide;4-methoxy-1-(2-methylpropyl)piperidine;[4-(2-methylpropyl)morpholin-2-yl]methanamine;[(2R)-1-(2-methylpropyl)piperazin-2-yl]methanol;[(2S)-1-(2-methylpropyl)piperazin-2-yl]methanol;(2S)-1-(2-methylpropyl)pyrrolidin-2-amine;(2R)-1-(2-methylpropyl)pyrrolidin-2-amine;N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]cyclopropanecarboxamide has a molecular weight of 1597.50 g/mol, XLogP of 5.20, 28 rotatable bonds, 12 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for 2-hydroxy-N-[1-(2-methylpropyl)piperidin-4-yl]acetamide;2-hydroxy-N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]acetamide;4-methoxy-1-(2-methylpropyl)piperidine;[4-(2-methylpropyl)morpholin-2-yl]methanamine;[(2R)-1-(2-methylpropyl)piperazin-2-yl]methanol;[(2S)-1-(2-methylpropyl)piperazin-2-yl]methanol;(2S)-1-(2-methylpropyl)pyrrolidin-2-amine;(2R)-1-(2-methylpropyl)pyrrolidin-2-amine;N-[(3R)-1-(2-methylpropyl)pyrrolidin-3-yl]cyclopropanecarboxamide is sourced from PubChem (CID 167595298), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).